Page 1338 - Small Animal Internal Medicine, 6th Edition

1310 PART XII Oncology

Chun R, et al. Evaluation of a high-dose chemotherapy protocol O’Brien D, et al. Clinical characteristics and outcome in dogs with
splenic marginal zone lymphoma. J Vet Intern Med. 2013;27:949.
with no maintenance therapy for dogs with lymphoma. J Vet Qurollo BA, et al. Infection with Panola Mountain Ehrlichia sp. in
VetBooks.ir Chun R. Lymphoma: which chemotherapy protocol and why? Top a dog with atypical lymphocytes and clonal T-cell expansion. J
Intern Med. 2000;14:120.
Companion Anim Med. 2009;24:157.
Vet Intern Med. 2013;27:1251.
Couto KM, et al. Clinical characteristics and outcome in dogs Rau SE, Barber LG, Burgess KE. Efficacy of maropitant in the pre-
with small cell T-cell intestinal lymphoma. Vet Comp Oncol. vention of delayed vomiting associated with administration of
2018;14:547. doxorubicin to dogs. J Vet Intern Med. 2010;24(6):1452–1457.
Deravi N, et al. Specific immunotypes of canine T cell lymphoma doi:10.1111/j.1939-1676.2010.0611.x. [Epub 2010 Oct 12].
are associated with different outcomes. Vet Immunol Immuno- Risbon RE, et al. Response of canine cutaneous epitheliotropic lym-
pathol. 2017;191:5. phoma to lomustine (CCNU): a retrospective study of 46 cases
Desmas I, et al. Clinical presentation, treatment and outcome in 31 (1999-2004). J Vet Intern Med. 2006;20:1389.
dogs with presumed primary colorectal lymphoma (2001-2013). Saba CF, et al. Rabacfosadine for relapsed canine B-cell lymphoma:
Vet Comp Oncol. 2017;15:504. efficacy and adverse event profiles of 2 different doses. Vet Comp
Ferreri AJM, et al. Infectious agents and lymphoma development: Oncol. 2018;16:76.
molecular and clinical aspects. J Intern Med. 2009;265:421. Saba CF, Thamm DH, Vail DM. Combination chemotherapy with
Flood-Knapik KE, et al. Clinical, histopathological and immuno- L-asparaginase, lomustine, and prednisone for relapsed or refrac-
histochemical characterization of canine indolent lymphoma. tory canine lymphoma. J Vet Intern Med. 2007;21:127.
Vet Comp Oncol. 2013;11:272. Shelton GH, et al. Feline immunodeficiency virus and feline leuke-
Greenberg CB, et al. Phase II clinical trial of combination chemo- mia virus infection and their relationships to lymphoid malig-
therapy with dexamethasone for lymphoma in dogs. J Am Anim nancies in cats: a retrospective study. J AIDS. 1990;3:623.
Hosp Assoc. 2007;43:27. Stein TJ, et al. Treatment of feline gastrointestinal small-cell lym-
Hosoya K, et al. COAP or UW-19 treatment of dogs with multicen- phoma with chlorambucil and glucocorticoids. J Am Anim Hosp
tric lymphoma. J Vet Intern Med. 2007;21:1355. Assoc. 2010;46:413.
Ito D, et al. A tumor-related lymphoid progenitor population sup- Taylor SS, et al. Serum protein electrophoresis in 155 cats. J Fel Med
ports hierarchical tumor organization in canine B-cell lym- Surg. 2010;12:643.
phoma. J Vet Intern Med. 2011;25:890. Teske E, et al. Prognostic factors for treatment of malignant lym-
Kiselow MA, et al. Outcome of cats with low-grade lymphocytic phoma in dogs. J Am Vet Med Assoc. 1994;205:1722.
lymphoma: 41 cases (1995-2005). J Am Vet Med Assoc. Valli VE, et al. Canine lymphomas: association of classification
2008;232:405. type, disease stage, tumor subtype, mitotic rate, and treatment
Lana SE, et al. Utility of polymerase chain reaction for analysis of with survival. Vet Pathol. 2013;50:738.
antigen receptor rearrangement in staging and predicting prog- Willcox JL, et al. Autologous peripheral blood hematopoietic cell
nosis in dogs with lymphoma. J Vet Intern Med. 2006;20:329. transplantation in dogs with B-cell lymphoma. J Vet Intern Med.
Lane AE, et al. Use of recombinant human granulocyte colony- 2012;26:1155.
stimulating factor prior to autologous bone marrow transplanta- Williams LE, et al. CCNU in the treatment of canine epitheliotropic
tion in dogs with lymphoma. Am J Vet Res. 2012;73:894. lymphoma. J Vet Intern Med. 2006;20:136.
Louwerens M, et al. Feline lymphoma in the post-feline leukemia Withers SS, et al. Fasting reduces the incidence of delayed-type
virus era. J Vet Intern Med. 2005;19:329. vomiting associated with doxorubicin treatment in dogs with
Modiano JF, et al. Distinct B-cell and T-cell lymphoproliferative lymphoma. Transl Oncol. 2014;doi:10.1016/j.tranon.2014.04.014.
disease prevalence among dog breeds indicates heritable risk. pii: S1936-5233(14)00049-7. [Epub ahead of print].
Cancer Res. 2005;65:5654. Zwingenberger AL, et al. Ultrasonographic evaluation of the mus-
Mooney SC, et al. Treatment and prognostic factors in lymphoma cularis propria in cats with diffuse small intestinal lymphoma or
in cats: 103 cases (1977-1981). J Am Vet Med Assoc. 1989;194:696. inflammatory bowel disease. J Vet Intern Med. 2010;24:289.
Morges MA, et al. Phase II evaluation of VDC-1101 in canine cuta-
neous T-cell lymphoma. J Vet Intern Med. 2014;28.